Cinnabaramides A-G:: Analogues of lactacystin and salinosporamide from a terrestrial streptomycete

被引:79
作者
Stadler, Marc
Bitzer, Jens
Mayer-Bartschmid, Anke
Mueller, Hartwig
Benet-Buchholz, Jordi
Gantner, Florian
Tichy, Hans-Volker
Reinemer, Peter
Bacon, Kevin B.
机构
[1] InterMed Discovery GmbH, IMD, D-44227 Dortmund, Germany
[2] Bayer HealthCare, Div Pharma, D-42096 Wuppertal, Germany
[3] Inst Chem Res Catalonia ICIQ, E-43007 Tarragona, Spain
[4] Boehringer Ingelheim GmbH & Co KG, D-88397 D Biberach, Germany
[5] LUFA ITL GmbH, D-24116 Kiel, Germany
[6] Proteros Biostruct GmbH, D-82152 Martinsried, Germany
[7] Actimis Pharmaceut, La Jolla, CA 92037 USA
来源
JOURNAL OF NATURAL PRODUCTS | 2007年 / 70卷 / 02期
关键词
D O I
10.1021/np060162u
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The cinnabaramides A-G (1-7) were isolated from a terrestrial strain of Streptomyces as potent and selective inhibitors of the human 20S proteasome. Their chemical and biological properties resemble those of salinosporamide A, a recently identified lead compound from an obligate marine actinomycete, which is currently under development as an anticancer agent. Cinnabaramides F and G (6, 7) combine essential structural features of salinosporamide A and lactacystin and show about equal potency in vitro, with IC50 values in the 1 nM range. The properties and phylogenetic position of the producer organism, the production and isolation of compounds 1-7, their structure elucidation by MS and NMR, and their biological activities are reported. Additionally, an X-ray crystal structure was obtained from cinnabaramide A (1).
引用
收藏
页码:246 / 252
页数:7
相关论文
共 25 条
[1]  
Bacon K., 2004, Substituted heterocycles, Patent No. [071, 382, 2004071382, WO2004071382]
[2]   A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib [J].
Chauhan, D ;
Catley, L ;
Li, GL ;
Podar, K ;
Hideshima, T ;
Velankar, M ;
Mitsiades, C ;
Mitsiades, N ;
Yasui, H ;
Letai, A ;
Ovaa, H ;
Berkers, C ;
Nicholson, B ;
Chao, TH ;
Neuteboom, STC ;
Richardson, P ;
Palladino, MA ;
Anderson, KC .
CANCER CELL, 2005, 8 (05) :407-419
[3]   THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY [J].
CIECHANOVER, A .
CELL, 1994, 79 (01) :13-21
[4]  
Corey EJ, 1998, ANGEW CHEM INT EDIT, V37, P1676, DOI 10.1002/(SICI)1521-3773(19980703)37:12<1676::AID-ANIE1676>3.0.CO
[5]  
2-T
[6]   Structure and functions of the 20S and 26S proteasomes [J].
Coux, O ;
Tanaka, K ;
Goldberg, AL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :801-847
[7]   Total synthesis of salinosporamide A [J].
Endo, A ;
Danishefsky, SJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (23) :8298-8299
[8]   Salinosporamide A:: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora [J].
Feling, RH ;
Buchanan, GO ;
Mincer, TJ ;
Kauffman, CA ;
Jensen, PR ;
Fenical, W .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (03) :355-+
[9]   Lactacystin, proteasome function, and cell fate [J].
Fenteany, G ;
Schreiber, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8545-8548
[10]   Crystal structures of salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of β-lactone ring opening and a mechanism for irreversible binding [J].
Groll, M ;
Huber, R ;
Potts, BCM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (15) :5136-5141